EMILY MILLER: Open Payments
NPI 1609511773 · WILLIAMSPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 93 payments from 18 companies in 2025. Trend: 2023 $1,584 · 2024 $1,662 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $427 |
| Novo Nordisk Inc | 14 | $250 |
| AstraZeneca Pharmaceuticals LP | 6 | $150 |
| PFIZER INC. | 10 | $148 |
| Lilly USA, LLC | 9 | $129 |
| Amgen Inc. | 7 | $111 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Dexcom, Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: VRAYLAR, QULIPTA, Ozempic, MOUNJARO, EVENITY, BREZTRI, NURTEC ODT, Wegovy.
Industry payments across PA — which companies pay providers there.
